Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
細分 Amylyx Pharma：9 位分析師分享他們的觀點
Amylyx Pharma (NASDAQ:AMLX) underwent analysis by 9 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Amylyx Pharma（納斯達克股票代碼：AMLX）在上個季度接受了9位分析師的分析，揭示了從看漲到看跌的一系列觀點。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
下表彙總了他們最近的評級，闡明瞭過去30天內情緒的變化，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $9.22, a high estimate of $32.00, and a low estimate of $3.00. Highlighting a 66.73% decrease, the current average has fallen from the previous average price target of $27.71.
分析師12個月目標股價的見解已經公佈，平均目標股價爲9.22美元，最高估計爲32.00美元，低估值爲3.00美元。當前的平均價格已從之前的27.71美元的平均目標股價有所下降，這凸顯了66.73％的跌幅。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級：仔細觀察
A comprehensive examination of how financial experts perceive Amylyx Pharma is derived...
對金融專家如何看待Amy...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。